GlycoNAVI: CheGly (Chemical Glycosylation)
ACT

Cleistetroside-3

ID Compound Name Target Name Species Assay Method Activity Value Conditions DOI
act2228Cleistetroside-3E. coli MG1655MIC (μM)>6410.1021/ml300303g
act2236Cleistetroside-3E. coli impMIC (μM)>6410.1021/ml300303g
act2244Cleistetroside-3B. subtilis JH642MIC (μM)810.1021/ml300303g
act2252Cleistetroside-3NCI-H460MIC (μM)12.810.1021/ml300303g
act2260Cleistetroside-3RPMI-8226 (leukemia)GI50 (μM)2.8410.1021/ml300303g
act2266Cleistetroside-3SR (leukemia)GI50 (μM)3.8310.1021/ml300303g
act2272Cleistetroside-3A549 (nonsmall cell lung cancer)GI50 (μM)8.1810.1021/ml300303g
act2278Cleistetroside-3NCI-H460 (nonsmall cell lung cancer)GI50 (μM)8.4310.1021/ml300303g
act2284Cleistetroside-3HCT-15 (colon cancer)GI50 (μM)8.3310.1021/ml300303g
act2290Cleistetroside-3HT-29 (colon cancer)GI50 (μM)8.1310.1021/ml300303g
act2296Cleistetroside-3SF-539 (CNS cancer)GI50 (μM)7.1710.1021/ml300303g
act2302Cleistetroside-3SNB-75 (CNS cancer)GI50 (μM)2.1810.1021/ml300303g
act2308Cleistetroside-3MDA-MB-435 (melanoma)GI50 (μM)7.2510.1021/ml300303g
act2314Cleistetroside-3SK-MEL-5 (melanoma)GI50 (μM)6.2710.1021/ml300303g
act2320Cleistetroside-3OVCAR-3 (ovarian cancer)GI50 (μM)6.0710.1021/ml300303g
act2326Cleistetroside-3ADR-R (ovarian cancer)GI50 (μM)8.9010.1021/ml300303g
act2332Cleistetroside-3A498 (renal cancer)GI50 (μM)5.6410.1021/ml300303g
act2338Cleistetroside-3CAKI-1 (renal cancer)GI50 (μM)9.2410.1021/ml300303g
act2344Cleistetroside-3PC-3 (prostate cancer)GI50 (μM)6.5510.1021/ml300303g
act2350Cleistetroside-3DU-145 (prostate cancer)GI50 (μM)7.4710.1021/ml300303g
act2356Cleistetroside-3MCF7 (breast cancer)GI50 (μM)5.2910.1021/ml300303g
act2362Cleistetroside-3BT-549 (breast cancer)GI50 (μM)8.3910.1021/ml300303g